These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 26614)

  • 1. Evaluation of in vitro and in vivo activities of isoantibodies directed against idiotypes and recognition structures for transplantation antigens.
    Kinsky RG; Duc HT; Fuensalida E
    Folia Biol (Praha); 1978; 24(2):81-94. PubMed ID: 26614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antigenic sites implicated in tumour allograft enhancement].
    Duc HT; Kinsky RG; Voisin GA
    Ann Immunol (Paris); 1977; 128(1-2):19-20. PubMed ID: 322579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking activity of the serum from semiallogeneic chimaeras produced by means of cyclophosphamide.
    Nagurskaya EV; Chernyakhovskaya IJ; Fontalin LN
    Folia Biol (Praha); 1984; 30(4):209-20. PubMed ID: 6383881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ia versus K/D antigens in immunological enhancement of tumour allografts. II. Studies with alloimmune sera prepared in recombinant strains.
    Duc HT; Kinsky RG; Voisin GA
    Ann Immunol (Paris); 1979; 130C(3):461-74. PubMed ID: 475347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation tolerance at the T-lymphocyte receptor level. II. Interaction of T-cell receptors with alloantigen and with anti-receptor antiserum.
    Ramseier H
    Exp Cell Biol; 1976; 44(1):44-64. PubMed ID: 1087255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of mixed leukocyte culture by anti-idiotypic antibodies.
    Binz H; Askonas BA
    Eur J Immunol; 1975 Sep; 5(9):618-23. PubMed ID: 11993322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antilymphocytic antibodies and marrow transplantation. VI. Absence of immunosuppression in vivo after injection of monoclonal antibodies blocking graft-versus-host reactions and humoral antibody formation in vitro.
    Thierfelder S; Hoffmann-Fezer G; Rodt H; Doxiadis I; Eulitz M; Kummer U
    Transplantation; 1983 Mar; 35(3):249-54. PubMed ID: 6340277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Morphological manifestations and morphogenesis of the graft vs. host reaction in the brain of F1 hybrids following the administration of parental lymphoid cells and its effect on tumor inoculation].
    Zarudin VV; Shcherbakov VIa
    Arkh Patol; 1975; 37(4):60-5. PubMed ID: 984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed against T cells or their subsets. I. Evidence for the induction of a state of tolerance based on suppression.
    Knulst AC; Tibbe GJ; Noort WA; Bril-Bazuin C; Benner R; Savelkoul HF
    Bone Marrow Transplant; 1994 Mar; 13(3):293-301. PubMed ID: 8199571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of burn injury on the reactivity of spleen cells of mice of different genotypes during regional graft vs host reaction].
    Barsukov AN; Fedorov GN; Semenkov VF
    Biull Eksp Biol Med; 1990 Jun; 109(6):592-4. PubMed ID: 2397303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Suppressors of the graft vs graft reaction in tolerance to alloantigens].
    Cherniakhovskaia IIu; Prigozhina TB; Nagurskaia EV; Fontalin LN
    Biull Eksp Biol Med; 1988 Jun; 105(6):697-700. PubMed ID: 2968819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunoglobulin nature of the antigen recognition site on cells mediating transplantation immunity and delayed hypersentivity.
    Mason S; Warner NL
    J Immunol; 1970 Mar; 104(3):762-5. PubMed ID: 4190976
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro studies of the genetically determined unresponsiveness to thymus-independent antigens in CBA/N mice.
    Cohen PL; Scher I; Mosier DE
    J Immunol; 1976 Feb; 116(2):301-4. PubMed ID: 55435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Status of T- and B-lymphocytes in long living CBA--F1 (CBA X C57BL/6) chimeras].
    Cherniakhovskaia IIu; Nesterenko VG; Filitis LN; Fontalin LN; Novikova TK
    Biull Eksp Biol Med; 1978 Aug; 86(8):197-200. PubMed ID: 28802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunochemotherapy of transplantable Moloney leukemia with cyclophosphamide and allogeneic spleen lymphocytes and reversal of graft-versus-host disease with alloantiserum.
    Kende M; Keys LD; Gaston M; Goldin A
    Cancer Res; 1975 Feb; 35(2):346-51. PubMed ID: 234033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of prodigiosin and its combination with immunodepressants on the graft versus host reaction in mice].
    Alekhin EK; Shigaev NI
    Antibiotiki; 1983 Nov; 28(11):842-5. PubMed ID: 6651274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of T15-specific suppressor T cells in mice with the CBA/N defect by neonatal injection with anti-T15 idiotype antibody.
    Kim BS; Massey PB
    J Immunol; 1982 Mar; 128(3):1145-8. PubMed ID: 6173422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the immune response to transplantation antigens. III. Further studies on the effects of Freund's complete adjuvant on the immune response of mice to allogeneic tumour antigen.
    Zola H
    Clin Exp Immunol; 1974 Mar; 16(3):469-79. PubMed ID: 4157121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the induction and expression of T cell-mediated immunity. IV. Non-overlapping populations of alloimmune cytotoxic lymphocytes with specificity for tumor-associated antigens and transplantation antigens.
    Kedar E; Bonavida B
    J Immunol; 1975 Nov; 115(5):1301-8. PubMed ID: 51889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytotoxic lymphocytes and anti-tumor immunity].
    Cerottini JC; Brunner KT
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):659-68. PubMed ID: 4403239
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.